相关实验视频

Updated: Sep 12, 2025

Measurement of Chitinase Activity in Biological Samples

Measurement of Chitinase Activity in Biological Samples

Published on: August 22, 2019

基因酶3样蛋白1作为炎症疾病的治疗点

Sun Mi Gu¹, Tae Hun Kim¹, Jeong Ho Park²

¹College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju 28160, Republic of Korea.

Biomolecules & therapeutics

|August 6, 2025

概括

基因酶-3样蛋白1 (CHI3L1) 在类风湿关节炎和阿尔茨海默氏症等疾病中驱动炎症. 抑制CHI3L1对这些疾病具有治疗前景.

科学领域:

免疫学免疫学免疫学
生物化学生物化学
病理生理学病理生理学

背景情况:

基因酶-3样蛋白1 (CHI3L1) 是一种分泌的葡萄糖蛋白,涉及巨细胞极化,亡和炎症.
在许多炎症和免疫性疾病中观察到CHI3L1表达的升高,包括类风湿关节炎,阿尔茨海默病和亚托邦性皮肤炎.
CHI3L1在释放促炎细胞因子中的作用表明它参与了广泛的炎症状况.

研究的目的:

审查目前关于CHI3L1在各种炎症状况中的功能作用的发现.
阐明CHI3L1在疾病发展中的病理生理和药理机制.
基于临床前证据,突出CHI3L1抑制的治疗潜力.

主要方法:

文献综述综合了关于CHI3L1.1.的最新研究.
对CHI3L1参与关键炎症信号通路的分析.
评估支持CHI3L1作为治疗点的临床前数据.

主要成果:

CHI3L1对各种炎症和免疫性疾病的发病有显著的贡献.
CHI3L1影响关键信号通路,参与炎症和疾病进展.
临床前研究表明,CHI3L1抑制在疾病模型中的有效性.

结论:

CHI3L1是广泛的炎症性疾病的关键调解者.
准CHI3L1是一个有前途的治疗策略.
需要对CHI3L1向干预措施进行进一步的临床研究.

关键词:

奇丁酶-3类蛋白 1 类蛋白 1 类蛋白炎症性疾病是一种炎症性疾病.治疗目标是治疗的目标.

更多相关视频

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

Efficient Production and Purification of Recombinant Murine Kindlin-3 from Insect Cells for Biophysical Studies

Efficient Production and Purification of Recombinant Murine Kindlin-3 from Insect Cells for Biophysical Studies

Published on: March 19, 2014

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...